Balchem Company Insiders

BCPC Stock  USD 145.07  1.35  0.94%   
Balchem's insiders are aggressively selling. The analysis of insiders' sentiment of trading Balchem stock suggests that all insiders are panicking at this time. Balchem employs about 1.3 K people. The company is managed by 32 executives with a total tenure of roughly 158 years, averaging almost 4.0 years of service per executive, having 40.69 employees per reported executive.
Theodore Harris  CEO
CEO and President and Director
Dino Rossi  Chairman
Executive Chairman

Balchem's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-02-26William A BackusDisposed 7000 @ 155.19View
2024-02-23William A BackusDisposed 9180 @ 156.37View
2024-02-22Theodore L HarrisDisposed 34350 @ 154.29View
2024-02-21William A BackusDisposed 15000 @ 154.73View
2023-09-11David B FischerDisposed 3800 @ 131.57View
2023-05-02Michael Robert SestrickDisposed 2300 @ 130.36View
Monitoring Balchem's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.

Balchem's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Balchem's future performance. Based on our forecasts, it is anticipated that Balchem will maintain a workforce of about 1300 employees by May 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Balchem's latest congressional trading

Congressional trading in companies like Balchem, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Balchem by those in governmental positions are based on the same information available to the general public.
2021-12-02Representative Josh GottheimerDisposed Under $15KVerify
2020-05-21Representative Gilbert CisnerosAcquired Under $15KVerify
2019-06-24Representative Donna ShalalaDisposed Under $15KVerify
2015-02-13Senator Thom TillisAcquired Under $15KVerify

Balchem Management Team Effectiveness

The company has return on total asset (ROA) of 0.0609 % which means that it generated a profit of $0.0609 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.109 %, meaning that it created $0.109 on every $100 dollars invested by stockholders. Balchem's management efficiency ratios could be used to measure how well Balchem manages its routine affairs as well as how well it operates its assets and liabilities. At present, Balchem's Return On Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.17, whereas Return On Tangible Assets are forecasted to decline to 0.12. At present, Balchem's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 15.7 M, whereas Net Tangible Assets are forecasted to decline to about 129 M.
The current year's Net Income Applicable To Common Shares is expected to grow to about 127.2 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 30 M.

Balchem Workforce Comparison

Balchem is rated second in number of employees category among related companies. The total workforce of Materials industry is currently estimated at about 9,015. Balchem retains roughly 1,302 in number of employees claiming about 14% of all equities under Materials industry.

Balchem Profit Margins

The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.440.3275
Significantly Up
Very volatile
Net Profit Margin0.07410.1177
Way Down
Very volatile
Operating Profit Margin0.110.1931
Way Down
Very volatile
Pretax Profit Margin0.10.1488
Way Down
Pretty Stable
Return On Assets0.110.0668
Way Up
Slightly volatile
Return On Equity0.170.103
Way Up
Slightly volatile

Balchem Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Balchem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Balchem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Balchem insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
1.3
52
40
 225,233 
 171,001 
2023-03-01
1.9524
41
21
 105,603 
 33,953 
2022-09-01
1.0
4
4
 135,000 
 5,030 
2022-03-01
0.8529
29
34
 85,575 
 41,437 
2021-09-01
1.0
2
2
 14,348 
 22,768 
2021-03-01
1.9286
27
14
 78,592 
 29,545 
2020-03-01
2.6
26
10
 72,588 
 26,611 
2019-09-01
0.75
3
4
 15,750 
 23,438 
2019-03-01
1.5625
25
16
 95,036 
 44,578 
2018-12-01
0.6667
2
3
 1,782 
 2,258 
2018-03-01
1.7857
25
14
 80,398 
 51,821 
2017-03-01
1.1429
16
14
 113,878 
 125,897 
2016-09-01
0.25
2
8
 24,000 
 54,900 
2016-06-01
0.5
6
12
 32,363 
 112,000 
2016-03-01
1.5
15
10
 121,094 
 39,437 
2015-09-01
0.7778
7
9
 58,700 
 93,033 
2015-06-01
0.875
14
16
 129,680 
 146,556 
2015-03-01
1.4
21
15
 166,705 
 134,828 
2014-12-01
0.9333
14
15
 112,456 
 138,512 
2014-09-01
1.2222
11
9
 115,200 
 115,200 
2014-06-01
1.1667
7
6
 97,752 
 87,403 
2014-03-01
1.1333
17
15
 154,192 
 125,763 
2013-12-01
0.6154
16
26
 122,742 
 222,493 
2013-09-01
0.65
13
20
 134,526 
 175,340 
2013-06-01
1.25
15
12
 149,981 
 110,178 
2013-03-01
1.1818
13
11
 191,546 
 149,726 
2012-12-01
1.0833
13
12
 74,133 
 72,444 
2012-09-01
1.0
2
2
 24,700 
 29,400 
2012-06-01
0.25
1
4
 2,500 
 5,000 
2012-03-01
1.8333
11
6
 137,275 
 50,302 
2011-12-01
1.2857
18
14
 109,537 
 139,029 
2011-09-01
0.5
1
2
 3,000 
 3,000 
2011-06-01
1.0
2
2
 18,150 
 18,150 
2011-03-01
2.0
6
3
 21,190 
 17,100 
2010-12-01
1.5625
25
16
 260,347 
 166,989 
2010-09-01
1.1111
10
9
 115,075 
 101,585 
2010-06-01
1.0
5
5
 42,000 
 35,100 
2010-03-01
1.0
1
1
 1,500 
 1,500 
2009-12-01
6.6667
20
3
 154,325 
 53,000 
2009-09-01
1.0
4
4
 62,775 
 62,775 
2009-06-01
1.5
15
10
 206,900 
 153,761 
2009-03-01
1.0
4
4
 38,011 
 50,011 
2008-06-01
3.0
3
1
 33,951 
 33,951 
2008-03-01
10.0
20
2
 243,761 
 38,011 
2007-12-01
2.0
2
1
 21,600 
 4,500 
2007-03-01
2.0
20
10
 138,400 
 76,200 
2006-12-01
0.4444
52
117
 380,700 
 108,406 
2006-03-01
0.08
4
50
 11,552 
 60,904 
2005-12-01
0.3125
5
16
 15,000 
 25,100 
2005-09-01
1.2
6
5
 118,000 
 22,100 
2005-06-01
0.8889
16
18
 40,200 
 29,000 
2005-03-01
0.8571
12
14
 92,747 
 61,070 
2004-12-01
0.3125
10
32
 49,830 
 96,060 
2004-09-01
1.5
6
4
 64,000 
 6,000 
2004-06-01
7.0
7
1
 34,050 
 4,500 
2003-12-01
9.0
9
1
 59,288 
 1,000.00 
2003-09-01
0.1667
1
6
 3,073 
 9,348 
2003-06-01
0.5
1
2
 280.00 
 10,324 

Balchem Notable Stakeholders

A Balchem stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Balchem often face trade-offs trying to please all of them. Balchem's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Balchem's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Theodore HarrisCEO and President and DirectorProfile
Dino RossiExecutive ChairmanProfile
John KuehnerVice President - Operations, Executive OfficerProfile
Francis FitzpatrickVice President - AdministrationProfile
Scott MasonVice President of Manufacturing and Supply ChainProfile
Mary CoelhoCFO, Chief Accounting OfficerProfile
Terry CoelhoCFO, Chief Accounting OfficerProfile
William BackusCFOProfile
Martin BengtssonCFOProfile
Michael SestrickSenior CTOProfile
Paul CoombsIndependent DirectorProfile
Edward McMillanIndependent DirectorProfile
David FischerIndependent DirectorProfile
John TelevantosLead Independent DirectorProfile
Daniel KnutsonDirectorProfile
Matthew WineingerDirectorProfile
Perry PremdasIndependent DirectorProfile
Hatsuki MiyataGeneral VPProfile
William CPAVP OfficerProfile
David LudwigGeneral Manager of ARC Specialty Products and VPProfile
Frederic BonedSenior HealthProfile
Brent TignorSenior OfficerProfile
Karin McCafferyIR ContactProfile
Carl BengtssonCFO TreasurerProfile
Job GunsterenSenior ProductsProfile
Mark StachGeneral Counsel, SecretaryProfile
Jonathan GriffinSenior DevelopmentProfile
CPA CPAChief OfficerProfile
Suzanne HartIR Contact OfficerProfile
Mary BrushIR Contact OfficerProfile
Matthew HoustonGeneral Counsel and SecretaryProfile
Martin ReidSenior OfficerProfile

About Balchem Management Performance

The success or failure of an entity such as Balchem often depends on how effective the management is. Balchem management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Balchem management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Balchem management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.17  0.12 
Return On Capital Employed 0.12  0.21 
Return On Assets 0.07  0.11 
Return On Equity 0.10  0.17 
The data published in Balchem's official financial statements usually reflect Balchem's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Balchem. For example, before you start analyzing numbers published by Balchem accountants, it's critical to develop an understanding of what Balchem's liquidity, profitability, and earnings quality are in the context of the Chemicals space in which it operates.
Please note, the presentation of Balchem's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Balchem's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Balchem's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Balchem. Please utilize our Beneish M Score to check the likelihood of Balchem's management manipulating its earnings.

Balchem Workforce Analysis

Traditionally, organizations such as Balchem use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Balchem within its industry.

Balchem Manpower Efficiency

Return on Balchem Manpower

Revenue Per Employee708.5K
Revenue Per Executive28.8M
Net Income Per Employee83.4K
Net Income Per Executive3.4M
Working Capital Per Employee127.3K
Working Capital Per Executive5.2M
When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Balchem Stock analysis

When running Balchem's price analysis, check to measure Balchem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Balchem is operating at the current time. Most of Balchem's value examination focuses on studying past and present price action to predict the probability of Balchem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Balchem's price. Additionally, you may evaluate how the addition of Balchem to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is Balchem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.243
Dividend Share
0.79
Earnings Share
3.35
Revenue Per Share
28.729
Quarterly Revenue Growth
(0.02)
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.